Cipro tablets contain ciprofloxacin and are used for selected bacterial infections in adults. The dose is decided individually, taking age, other medicines, kidney function, infection severity, and health conditions into account. Ciprofloxacin stops bacterial DNA replication, producing a bactericidal effect against susceptible organisms.
Cipro contains ciprofloxacin, a synthetic fluoroquinolone antibiotic. Ciprofloxacin acts against bacteria rather than viruses, so it has no role in colds, influenza, or other viral illnesses. The dose is decided individually, taking age, other medicines, kidney function, infection severity, and health conditions into account.
Ciprofloxacin targets two bacterial enzymes:
The drug reaches useful concentrations in urine and several tissues. Its suitability depends on the organism, infection site, kidney function, previous antibiotic exposure, and local resistance patterns. The FDA prescribing information describes ciprofloxacin as an antibacterial fluoroquinolone with activity against susceptible Gram-negative and selected Gram-positive bacteria [1]. CDC and NICE publish additional guidance on matching antibiotic selection to the organism and infection site.
Human cells use different DNA-handling enzymes, which allows ciprofloxacin to target bacterial processes more selectively. The result is a concentration-dependent antibacterial effect, though exposure does not need to be increased beyond the prescribed regimen.
Resistance can develop when ciprofloxacin is used for an infection that it cannot treat, when doses are missed repeatedly, or when treatment is stopped without clinical direction. A culture and susceptibility test can help identify whether the organism is sensitive.
Cipro is supplied as oral tablets containing ciprofloxacin. Ciprofloxacin is the active ingredient and belongs to the fluoroquinolone antibiotic class.
The tablet is intended for oral administration. Its clinical role comes from the active substance, not from the tablet colour or coating. A prescriber may select a different antibiotic when the infection is viral, when the organism is resistant, or when a patient has a contraindication to fluoroquinolones. The dose is decided individually, taking age, other medicines, kidney function, infection severity, and health conditions into account.
| Product feature | Cipro |
|---|---|
| Dosage form | Oral tablet |
| Active ingredient | Ciprofloxacin |
| Strength | Ciprofloxacin tablet |
The dose is decided individually, taking age, other medicines, kidney function, infection severity, and health conditions into account. The prescribed course may differ between uncomplicated and complicated infections, and renal impairment can require adjustment.
Milk and yoghurt can also interfere with absorption when taken as the only liquid or food accompanying the tablet. A mixed meal usually behaves differently, but mineral supplements and antacids remain the more common practical problem.
Drink enough fluid to avoid dehydration unless a clinician has restricted fluids because of heart or kidney disease. Do not use leftover antibiotics for a new illness.
Cipro is not suitable for everyone. It is not for you if:
Tell the prescriber about epilepsy, seizures, diabetes, kidney disease, heart rhythm problems, aneurysm, steroid treatment, transplant history, or previous tendon problems. Ciprofloxacin can affect the central nervous system and may lower the seizure threshold.
Common adverse effects include nausea, diarrhoea, abdominal discomfort, headache, dizziness, insomnia, and changes in taste. These effects are often mild, though persistent or severe diarrhoea can indicate antibiotic-associated colitis.
Fluoroquinolones have important uncommon reactions that can be serious:
Stop physical activity and obtain urgent medical assessment if sudden Achilles or other tendon pain develops. Tendon damage can appear during treatment or weeks after the last tablet.
Sun sensitivity can occur. Use practical sun protection during treatment, especially if outdoor exposure causes a rash or burning more quickly than usual.
Cipro is used for selected bacterial infections in adults. Treatment should match the suspected or confirmed organism and the infection site. The EMA product information for ciprofloxacin describes indications that include certain urinary, respiratory, gastrointestinal, intra-abdominal, skin, bone, joint, and genital infections, with use restricted when other antibiotics are more suitable [2].
| Infection group | Examples of clinical use |
|---|---|
| Urinary and prostatic infections | Complicated cystitis, acute pyelonephritis, and chronic bacterial prostatitis caused by susceptible organisms |
| Respiratory and systemic infections | Selected lower respiratory infections and infections linked to susceptible Gram-negative bacteria |
| Gastrointestinal and other infections | Certain bacterial diarrhoeal, intra-abdominal, skin, bone, joint, or exposure-related infections |
Ciprofloxacin may be selected for complicated urinary tract infections, acute pyelonephritis, or chronic bacterial prostatitis when the organism is susceptible. It penetrates urinary tissues and reaches high urinary concentrations, which can support treatment of selected infections involving the kidneys or prostate.
Simple cystitis does not automatically require a fluoroquinolone. Prescribers often reserve ciprofloxacin for situations in which the likely organism, culture result, allergy history, resistance pattern, or infection severity supports its use.
Ciprofloxacin may be used for selected lower respiratory infections, though it is not a universal choice for community-acquired pneumonia. Its activity against some Gram-negative organisms can be useful when those organisms are suspected or confirmed.
Q fever requires specialist antibiotic selection because the causative organism and clinical presentation differ from routine urinary infections. Ciprofloxacin is not a self-selected treatment for Q fever; the diagnosis, pregnancy status, disease severity, and recommended regimen must guide therapy.
Ciprofloxacin is chosen by mechanism and susceptibility, not by the broad label “strong antibiotic.” A narrower antibiotic may be preferred when it covers the confirmed organism with fewer fluoroquinolone-specific risks.
| Approach | Typical clinical distinction |
|---|---|
| Ciprofloxacin, a fluoroquinolone | Useful for selected susceptible Gram-negative infections and some tissue sites; carries class-specific tendon, nerve, rhythm, and central nervous system warnings |
| Beta-lactam antibiotic | Often selected for susceptible respiratory, skin, urinary, or bloodstream infections according to the organism and allergy history |
| Macrolide antibiotic | Used for selected respiratory or atypical bacterial infections; has its own interaction and heart-rhythm considerations |
A clinician may prefer a beta-lactam for a confirmed susceptible infection when fluoroquinolone risks outweigh the benefits. Ciprofloxacin can be useful when tissue penetration, prior culture results, or resistance patterns favour it.
Several avoidable habits reduce treatment quality or increase risk:
One easy-to-miss issue is clozapine. Ciprofloxacin can increase clozapine exposure through enzyme inhibition, so the combination requires deliberate medical review rather than casual co-use.
Another is driving after dizziness or confusion appears. The medicine can impair alertness in some people even when the first dose caused no problem.
In clinical practice, doctors usually reserve ciprofloxacin for infections where its antibacterial spectrum and tissue distribution offer a clear benefit. A urine culture can be more valuable than simply escalating to a broader antibiotic when symptoms persist.
A clinician also weighs local resistance, renal function, age, tendon history, neurological conditions, and interacting medicines. The 2023 WHO AWaRe antibiotic book places fluoroquinolones within antimicrobial stewardship decisions, supporting targeted use rather than routine treatment for every urinary or respiratory symptom [3].
Patients sometimes expect improvement after the first tablet. Fever, pain, urinary symptoms, or cough may take time to settle, and worsening symptoms can signal an incorrect organism, a complication, or a need for reassessment. The prescriber may need to review culture results. Treatment response depends on the infection site and bacterial susceptibility. Follow-up is needed when symptoms worsen or fail to improve.
The practical goal is the narrowest suitable treatment. Cipro can be useful, but its fluoroquinolone risks make casual self-treatment inappropriate.
The FDA ciprofloxacin label does not describe a disulfiram-like alcohol reaction, but alcohol can worsen dizziness, nausea, sleep disturbance, or poor judgement during treatment. A 2016 FDA review also highlights central nervous system reactions and tendon warnings that can complicate assessment when alcohol is involved. Avoiding alcohol is a practical choice until the infection and any treatment-related symptoms have settled.
The medical review should cover allergies, kidney function, tendon disorders, seizures, myasthenia gravis, heart-rhythm problems, aortic disease, pregnancy, breastfeeding, and age. Medication details matter because the EMA product information identifies interactions involving tizanidine, theophylline, anticoagulants, clozapine, antacids, and mineral supplements. A 2025 medication review should also include non-prescription vitamins and sports supplements, which patients often forget to mention.
Seek urgent medical help for tendon pain or swelling, sudden weakness, numbness, severe confusion, hallucinations, seizure, fainting, major palpitations, facial swelling, breathing difficulty, or severe blistering rash. Bloody or persistent watery diarrhoea also requires prompt assessment because antibiotic-associated colitis can occur during or after treatment. EMA safety information reviewed in 2018 describes disabling and potentially long-lasting reactions involving tendons, nerves, muscles, joints, and the nervous system.
Ciprofloxacin may cause dizziness, tremor, insomnia, confusion, anxiety, visual symptoms, or reduced alertness in some people. The WHO antibiotic safety material published in 2023 supports avoiding hazardous tasks whenever neurological symptoms appear. Do not drive, climb, operate machinery, or perform safety-critical work until you know how the tablets affect concentration and coordination.
Ciprofloxacin tablets may be taken with or without food, with water. Avoid taking them at the same time as calcium, magnesium, aluminium, iron, zinc, antacids, or sucralfate because these substances can bind ciprofloxacin and reduce absorption. The EMA product information available in 2024 advises separating interacting mineral products from the antibiotic according to the prescribed instructions.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
